Jacobio Pharma
Jacobio Pharma (Jacobio Pharmaceutica) is a clinical-stage biopharmaceutical company focused on discovering and developing novel small-molecule cancer therapies against historically "undruggable" oncology targets. Its pipeline spans 10+ clinical programs across six major tumor signaling pathways (including p53, RAS, RB, MYC, immune checkpoints, and tumor metabolism), advanced through proprietary allosteric drug-discovery and iADC platforms, more than 300 global patent applications, and 100+ clinical centers worldwide. Surfaced as a portfolio company of the venture firm Qiming and added to the API Evangelist network; it publishes a corporate website but no public API or developer surface.
Jacobio Pharma is profiled on the APIs.io network. Tagged areas include Company, Pharmaceuticals, Biotechnology, Oncology, and Drug Discovery.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Company 1
The organization behind the API